CDSI News

Penicillin delabeling initiative expanding to more patient care areas

Given the stakes for patients and for public health, experts say current efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at…

Read More

Study shows success at disproving allergies to sulfa antibiotics

A Vanderbilt University Medical Center study published in Transplant Infectious Diseases shows that physicians can successfully identify and disprove low-risk sulfa (trimethoprim/…

Read More

Study seeks to disprove cephalosporin allergies

A Vanderbilt study done in the Drug Allergy Clinic and reported recently in the Journal of Allergy and Clinical Immunology: In Practice, shows that taking a careful history in patients who…

Read More

Hockey player, survivor supports TEN research

Hockey player Louis Chaix was forced to step away from the ice for a couple of years after he was diagnosed with an extremely rare disease called Steven Johnson Syndrome/Toxic Epidermal Necrolysis.…

Read More

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center…

Read More